Nicholas Lydon

Track

Insider profile

Currently holds a position at Blueprint Medicines Corp

Positions

Position Company Period
Independent Director Blueprint Medicines Corp Dec. 31, 2016 -
Independent Director AnaptysBio Inc None -
Director Blueprint Medicines Corp April 1, 2011 - Dec. 31, 2016
Nicholas Lydon's trades of Blueprint Medicines Corp's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2020-10-05 2020-10-01
PlS Planned sale
78,830 -21.6%
414.27
US$850,708 		78,830 -21.6% 414.27 US$850,708
2020-10-05 2020-10-01
PlS Planned sale
87,661 -25.0%
172.03
US$2,010,588 		87,661 -25.0% 172.03 US$2,010,588
2020-10-05 2020-10-01
PlS Planned sale
50,035 -25.2%
55.80
US$2,724,082 		50,035 -25.2% 55.80 US$2,724,082
2020-09-21 2020-09-17
PlS Planned sale
500 -1.0%
80.00
US$40,000 		500 -1.0% 80.00 US$40,000
2020-07-08 2020-07-06
PlS Planned sale
600 -1.2%
81.02
US$48,612 		600 -1.2% 81.02 US$48,612
2020-07-08 2020-07-06
PlS Planned sale
25,407 -34.5%
80.44
US$2,043,739 		25,407 -34.5% 80.44 US$2,043,739
2020-07-06 2020-07-02
PlS Planned sale
2,825 -3.7%
80.13
US$226,367 		2,825 -3.7% 80.13 US$226,367
2020-07-06 2020-07-01
PlS Planned sale
1,300 -1.7%
80.21
US$104,273 		1,300 -1.7% 80.21 US$104,273
2020-06-25 2020-06-23
PlS Planned sale
400 -0.5%
80.00
US$32,000 		400 -0.5% 80.00 US$32,000
2020-06-23 2020-06-22
PlS Planned sale
13,017 -14.6%
80.29
US$1,045,135 		13,017 -14.6% 80.29 US$1,045,135
2019-06-17 2019-06-13
PlS Planned sale
25,000 -16.4%
90.36
US$2,259,000 		25,000 -16.4% 90.36 US$2,259,000
2019-06-14 2019-06-12
PlS Planned sale
300 -0.2%
81.96
US$24,588 		300 -0.2% 81.96 US$24,588
2019-06-14 2019-06-12
PlS Planned sale
2,000 -1.3%
82.45
US$164,900 		2,000 -1.3% 82.45 US$164,900
2019-06-14 2019-06-12
PlS Planned sale
5,200 -3.2%
83.83
US$435,916 		5,200 -3.2% 83.83 US$435,916
2019-06-14 2019-06-12
PlS Planned sale
6,300 -3.8%
84.66
US$533,358 		6,300 -3.8% 84.66 US$533,358
2019-06-14 2019-06-12
PlS Planned sale
11,200 -6.3%
85.75
US$960,400 		11,200 -6.3% 85.75 US$960,400